Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Plus Therapeutics (PSTV) Times Interest Earned (2016 - 2025)

Plus Therapeutics (PSTV) has disclosed Times Interest Earned for 15 consecutive years, with -$6.45 as the latest value for Q1 2025.

  • On a quarterly basis, Times Interest Earned rose 93.35% to -$6.45 in Q1 2025 year-over-year; TTM through Sep 2025 was -$22.24, a 66.91% increase, with the full-year FY2024 number at -$82.09, down 143.43% from a year prior.
  • Times Interest Earned was -$6.45 for Q1 2025 at Plus Therapeutics, up from -$68.42 in the prior quarter.
  • In the past five years, Times Interest Earned ranged from a high of -$6.45 in Q1 2025 to a low of -$136.93 in Q2 2024.
  • A 5-year average of -$43.44 and a median of -$37.37 in 2023 define the central range for Times Interest Earned.
  • Peak YoY movement for Times Interest Earned: tumbled 929.24% in 2024, then skyrocketed 93.35% in 2025.
  • Plus Therapeutics' Times Interest Earned stood at -$17.5 in 2021, then plummeted by 115.2% to -$37.65 in 2022, then decreased by 6.74% to -$40.19 in 2023, then tumbled by 70.25% to -$68.42 in 2024, then skyrocketed by 90.57% to -$6.45 in 2025.
  • Per Business Quant, the three most recent readings for PSTV's Times Interest Earned are -$6.45 (Q1 2025), -$68.42 (Q4 2024), and -$62.28 (Q3 2024).